The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy response
Klára Plačková1,2, Anna Fialová1
1Sotio Biotech a.s., Prague, Czechia.
Abstract:
Human papillomavirus (HPV) is a DNA virus with oncogenic potential. Persistent infections with high-risk HPV genotypes can drive malignant transformation in multiple tissues, resulting in distinct HPV-associated cancers. This review provides an analysis of the tumor microenvironment (TME) in head and neck squamous cell carcinoma (HNSCC) and squamous cell carcinoma of uterine cervix (CESC). First, we briefly introduce the key aspects of HPV biology and the mechanisms of carcinogenesis. We focus on the composition and functional states of immune cells within tumor tissues, highlighting how specific immune cells influence disease progression and clinical outcomes. By linking immunological features to patient prognosis, we outline the similarities and differences between the TME of HNSCC and CESC. Additionally, this review summarizes the current standards of care and emerging therapeutic strategies for patients with HPV-associated tumors. Altogether, by providing recent advances in the understanding of the TME of HPV-associated tumors, this review highlights the potential of targeting immune components within the tumor microenvironment for therapeutic benefit.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment
The Tumor Microenvironment
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

